Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Gretel Monreal"'
Autor:
Gretel Monreal, Steven C. Koenig, Mark S. Slaughter, Gino F. Morello, Steven R. Prina, Landon H. Tompkins, Jiapeng Huang, Barry N. Gellman, Kurt A. Dasse
Publikováno v:
PLoS ONE, Vol 17, Iss 5 (2022)
Inspired Therapeutics (Merritt Island, FL) is developing a mechanical circulatory support (MCS) system designed as a single driver with interchangeable, extracorporeal, magnetically levitated pumps. The NeoMate system design features an integrated ce
Externí odkaz:
https://doaj.org/article/92270257b7db45c5b4f58b76809e3142
Autor:
Mark S Slaughter, Gretel Monreal, Steven C Koenig, Guruprasad A Giridharan, Landon H Tompkins, Jorge H Jimenez
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253299 (2021)
In the US, the most significant morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) is embolic stroke, with 90% of thrombus originating from the left atrial appendage (LAA). Anticoagulation is the preferred treatment for t
Externí odkaz:
https://doaj.org/article/d0d2079cc2ab4300be0cd83b6ba15e11
Autor:
Gretel Monreal, Steven C. Koenig, Mustafa Ertan Taskin, Charles Shambaugh, Jeffrey A. LaRose, Mark S. Slaughter
Publikováno v:
ASAIO Journal.
Publikováno v:
Heart, Lung and Circulation. 29:384-389
Reoperative coronary artery bypass grafting (redo-CABG) has declined during the last decade, while use of percutaneous coronary intervention (PCI) has increased. The aim of this retrospective study was to evaluate risk factors, in-hospital mortality,
Autor:
Gretel Monreal, Steven C. Koenig, Mark S. Slaughter, Gino F. Morello, Steven R. Prina, Landon H. Tompkins, Jiapeng Huang, Barry N. Gellman, Kurt A. Dasse
Publikováno v:
PloS one. 17(5)
Inspired Therapeutics (Merritt Island, FL) is developing a mechanical circulatory support (MCS) system designed as a single driver with interchangeable, extracorporeal, magnetically levitated pumps. The NeoMate system design features an integrated ce
Autor:
Landon H. Tompkins, Gretel Monreal, Steven C. Koenig, Jorge H. Jimenez, Mark S. Slaughter, Guruprasad A. Giridharan
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253299 (2021)
PLoS ONE
PLoS ONE
In the US, the most significant morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) is embolic stroke, with 90% of thrombus originating from the left atrial appendage (LAA). Anticoagulation is the preferred treatment for t
Publikováno v:
The Multimedia Manual of Cardio-Thoracic Surgery.
Left ventricular assist device (LVAD) treatment may lead to reverse remodeling in heart failure patients. Selected patients can recover heart function and be eligible for LVAD explantation. Surgical methods for explanting an LVAD have been reported u
Autor:
Stephen R. Carnahan, Michael A. Sobieski, Yu Wang, Brek J. Meuris, Young Choi, Zhongjun J. Wu, Guruprasad A. Giridharan, Landon H. Tompkins, Steven C. Koenig, Erin M. Schumer, Mark S. Slaughter, Gretel Monreal
Counterpulsation devices (CPD) require an accurate, reliable electrocardiogram (ECG) waveform for triggering inflation and deflation. Surface electrodes are for short-term use and transvenous/epicardial leads require invasive implant procedure. A sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef20033321471c1727f626f6e6dc4b29
https://europepmc.org/articles/PMC5898620/
https://europepmc.org/articles/PMC5898620/
Autor:
Jorge H. Jimenez, Kevin G. Soucy, Michael A. Sobieski, Mark S. Slaughter, Guruprasad A. Giridharan, Gretel Monreal, Seth West, Steven C. Koenig, Young Choi
Publikováno v:
ASAIO Journal. 60:617-625
APK Advanced Medical Technologies (Atlanta, GA) is developing a sutureless beating heart (SBH) left ventricular assist device (LVAD) connector system consisting of anchoring titanium coil, titanium cannula with integrated silicone hemostatic valve, c
Autor:
Guruprasad A. Giridharan, Leslie C. Sherwood, Gretel Monreal, Kevin G. Soucy, Steven C. Koenig, Mark S. Slaughter, Charles R. Shambaugh, Katherine Chorpenning, Daniel Tamez, Jeffrey A. LaRose, Michael A. Sobieski
Publikováno v:
ASAIO Journal. 60:170-177
Implantation of ventricular assist devices (VADs) for the treatment of end-stage heart failure (HF) falls decidedly short of clinical demand, which exceeds 100,000 HF patients per year. Ventricular assist device implantation often requires major surg